Hepatology International Q1 Unclaimed
Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences. Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports.. Hepatology International requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section. To visit our ethics statements please visit the following links: Conflict of Interest and Ethical Standards: http://www.springer.com/authors?SGWID=0-111-6-791531-0 Informed Consent: http://www.springer.com/authors?SGWID=0-111-6-608209-0 Statement of Human and Animal Rights: http://www.springer.com/authors?SGWID=0-111-6-608309-0 Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL).Now indexed by ISI A peer-reviewed journal with global reach and championed and edited by international experts in the fieldFocuses on the complete spectrum of contemporary clinical and basic science related issues in the field of adult and pediatric hepatobiliary and allied sciences, new and emerging technologies, cutting-edge innovations and future trends in liver and biliary disordersPublishes original research articles, editorials, reviews, consensus guidelines for diagnosis and treatment of liver diseases It has an SJR impact factor of 1,813.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,813
SJR Impact factor65
H Index172
Total Docs (Last Year)404
Total Docs (3 years)6229
Total Refs2445
Total Cites (3 years)334
Citable Docs (3 years)5.46
Cites/Doc (2 years)36.22
Ref/DocOther journals with similar parameters
Journal of Hepatology Q1
Nature Reviews Gastroenterology and Hepatology Q1
Lancet Gastroenterology and Hepatology, The Q1
The Lancet Gastroenterology and Hepatology Q1
Gastroenterology Q1
Compare this journals
Aims and Scope
Best articles by citations
Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study
View more"Fast, faster, and fastest: science on the run during COVID-19 drama"" - ""do not forget the liver"
View moreSmall intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
View moreEffects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma
View moreInterobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis
View moreAKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis
View morePeroxisome proliferators-activated receptor gamma2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients
View morePrecise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis
View moreHepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
View moreNoncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation
View moreAssessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis
View moreEffect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis
View moreApplied precision cancer medicine in metastatic biliary tract cancer
View moreClinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study
View moreEfficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
View moreIntroduction
View moreA comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-na?Øve patients with chronic hepatitis B
View moreSafety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma
View moreCharacterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
View moreGross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression
View moreMultiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation
View moreNon-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients
View moreEfficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding
View moreThe effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
View more
Comments